Clinical trial • Phase III • Oncology|Gastroenterology
Clinical trial in Colorectal cancer with peritoneal metastasis
Phase III trial for Colorectal cancer with peritoneal metastasis. 20 participants.
Overview
- Trial Therapeutic Area
- Oncology|Gastroenterology
- Trial Disease
- Colorectal cancer with peritoneal metastasis
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 16-10-2024
- First CTIS Authorization Date
- 14-11-2024
Trial design
Phase III trial across 1 site in Norway.
- Target Sample Size
- 20
Recruitment
- Planned Sample Size
- 20
- Recruitment Window Months
- 118
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 20
Norway
- Earliest CTIS Part Ii Submission Date
- 31-10-2024
- Latest Decision Or Authorization Date
- 14-11-2024
- Processing Time Days
- 14
- Number Of Sites
- 1
- Number Of Participants
- 20
Sites
- Site Name
- Oslo University Hospital HF
- Department Name
- Abdominal cancer surgery
- Principal Investigator Name
- Vegar Johansen Dagenborg
- Principal Investigator Email
- vegdag@ous-hf.no
- Contact Person Name
- Vegar Johansen Dagenborg
- Contact Person Email
- vegdag@ous-hf.no
- Number Of Participants
- 20
Sponsor
Primary sponsor
- Full Name
- Oslo University Hospital HF
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- Norway
Related trials
Other published trials that may interest you.
- Girentuximab (labelled with Zirconium-89) for Gastroenteropancreatic neuroendocrine neoplasms|Hepatocellular carcinoma|Biliary tract cancer
- DOSTARLIMAB for Resectable colon cancer (pMMR/MSS)
- D,L-LYSINE ACETYLSALICYLATE for Metastatic colorectal cancer|Chemo-resistant metastatic colorectal cancer
- BEVACIZUMAB for Advanced hepatocellular carcinoma|Liver transplant recipient
- Capecitabine for Gastric adenocarcinoma|Gastroesophageal junction adenocarcinoma